Science Explorer Back to mapMap
Discussion
Researcher · CHA University · South Korea

Young Joo Jeon

Young Joo Jeon publishes mostly in Molecular Biology, Cancer Research and Immunology, on topics such as Ubiquitin and proteasome pathways, MicroRNA in disease regulation and Folate and B Vitamins Research.

ORCID 0000-0003-1004-5336 OpenAlex
World rank
#1,130,338
of 7,710,434 ranked researchers
Rank in South Korea
#11,474
of 162,609
Works
156
Citations
4.8k
Citations per work
30.9
h-index
39
i10-index 95Top 7.8% in Molecular Biology
Young Joo Jeon

What does Young Joo Jeon research?

Young Joo Jeon's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Medicine (15%), Immunology and Microbiology (8%).

Everything else: 69 works · 44.0% of their workLife Sciences: 64 works · 41.0% of their workBiochemistry, Genetics and Molecular Biology: 52 works · 33.2% of their workMolecular Biology: 33 works · 21.0% of their workCancer Research: 19 works · 12.2% of their workImmunology and Microbiology: 12 works · 7.8% of their workImmunology: 12 works · 7.8% of their workHealth Sciences: 23 works · 15.0% of their workMedicine: 23 works · 15.0% of their workOncology: 9 works · 5.8% of their workRheumatology: 8 works · 5.3% of their workPulmonary and Respiratory Medicine: 6 works · 3.9% of their workTHEIR WORKYoung Joo Jeon156works
Life Sciences41%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else6944.0%
    1. Biochemistry, Genetics and Molecular Biology5233.2%
    2. Immunology and Microbiology127.8%
    1. Medicine2315.0%
  1. 1Molecular Biology21% of their works
  2. 2Cancer Research12% of their works
  3. 3Immunology8% of their works
  4. 4Oncology6% of their works
  5. 5Rheumatology5% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe Young Joo Jeon's research?

The keywords of their largest research topics: Endothelial Dysfunction, Cancer, Proteasome, Ubiquitin, Folate, Gene Expression, Homocysteine and MicroRNA.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Endothelial Dysfunction262 topics
  2. Cancer252 topics
  3. Proteasome211 topic
  4. Ubiquitin211 topic
  5. Folate151 topic
  6. Gene Expression151 topic
  7. Homocysteine151 topic
  8. MicroRNA151 topic
  9. Decidual NK Cells121 topic
  10. Innate Immunity121 topic
  11. Regulatory T Cells121 topic
  12. Viral Infection121 topic
  13. Placental Development111 topic
  14. Preeclampsia111 topic
  15. Fatty Acid Synthase101 topic
  16. HIF-1101 topic
  17. Lipid Metabolism101 topic
  18. Warburg Effect101 topic

Where does Young Joo Jeon work?

Young Joo Jeon's main affiliation in the publication record is CHA University, South Korea.

How many publications and citations does Young Joo Jeon have?

OpenAlex counts 156 works and 4,822 citations for Young Joo Jeon, an h-index of 39, ranking #1,130,338 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Young Joo Jeon

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Young Joo Jeon. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.